Skip to main content
HNGE logo

HNGE · Hinge Health, Inc. · Webcasts, Transcripts & Audio

Track HNGE — free
$97.67 -0.27 (-0.28%) At close · Oct 2
Market Cap
$7.71B
Shares
80.69M
Volume · Oct 2 975.35K Avg daily vol (3M) 1.77M

Hinge Health, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Hinge Health, Inc. (HNGE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-04
Hinge Health, Inc. (HNGE) Q2 2026 Earnings Call Transcript
Confident tone Migraine care program expansion Q2 financial performance and profitability Sales pipeline and win rates
Revenue
$212.82M
▲ 53% YoY
Diluted EPS
$0.52
Gross margin
86.4%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Hinge Health, Inc. (HNGE) Q1 2026 Earnings Call Transcript
Confident tone Quarterly financial performance Commercial pipeline and sales cycle ENSO device distribution and unit economics
Revenue
$182.31M
▲ 47.2% YoY
Diluted EPS
$0.41
▼ 68.7% YoY
Gross margin
84.6%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call Transcript
Confident tone Financial performance and growth Hinge Select provider network Market expansion and penetration
Revenue
$170.73M*
Gross margin
84.4%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Hinge Health, Inc. (HNGE) Q3 2025 Earnings Call Transcript
Confident tone Revenue and growth Profitability and cash flow Hinge Select expansion
Revenue
$154.21M
▲ 53.3% YoY
Diluted EPS
$-0.02
▼ 300% YoY
Gross margin
81.8%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Hinge Health, Inc. (HNGE) Q2 2025 Earnings Call Transcript
Confident tone Revenue and growth Market opportunity and TAM Channel partnerships and go-to-market
Revenue
$139.10M
▲ 54.9% YoY
Diluted EPS
$-13.10
Gross margin
70.3%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–5 of 5 webcasts
Key facts CIK 1673743 CUSIP 433313103 13F (30d) 7 filings 7 filers Visit website Investor relations